Epidermolysis Bullosa: Pediatric Perspectives.
Hon KL, Chu S, Leung AKC.
Curr Pediatr Rev. 2022;18(3):182-190. doi: 10.2174/1573396317666210525161252.
In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.
Gurevich I, Agarwal P, Zhang P, Dolorito JA, Oliver S, Liu H, Reitze N, Sarma N, Bagci IS, Sridhar K, Kakarla V, Yenamandra VK, O'Malley M, Prisco M, Tufa SF, Keene DR, South AP, Krishnan SM, Marinkovich MP.
Nat Med. 2022 Apr;28(4):780-788. doi: 10.1038/s41591-022-01737-y. Epub 2022 Mar 28.
Recessive Dystrophic Epidermolysis Bullosa: Advances in the Laboratory Leading to New Therapies.
Woodley DT, Chen M.
J Invest Dermatol. 2015 Jul;135(7):1705-1707. doi: 10.1038/jid.2015.149.
Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa.
Almaani N, Liu L, Dopping-Hepenstal PJ, Lai-Cheong JE, Wong A, Nanda A, Moss C, Martinéz AE, Mellerio JE, McGrath JA.
Acta Derm Venereol. 2011 May;91(3):262-6. doi: 10.2340/00015555-1053.
The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
Subramaniam KS, Antoniou MN, McGrath JA, Lwin SM.
Br J Dermatol. 2022 Apr;186(4):609-619. doi: 10.1111/bjd.20910. Epub 2022 Apr 1.
Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Santucci C, Alexandru M, Chen X, Mellerio JE, Karagiannis SN, Jacków-Malinowska J.
Hum Immunol. 2024 May;85(3):110805. doi: 10.1016/j.humimm.2024.110805. Epub 2024 May 4.
Dystrophic Epidermolysis Bullosa.
Yadav RS, Jayswal A, Shrestha S, Gupta SK, Paudel U.
JNMA J Nepal Med Assoc. 2018 Sep-Oct;56(213):879-882. doi: 10.31729/jnma.3791.
Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa.
Sacedón R, de Arriba MC, Martínez-Santamaría L, Maseda R, Herráiz-Gil S, Jiménez E, Rosales I, Quintana L, Illera N, García M, Butta N, Fernández-Bello I, Lwin SM, Fernández-Arquero M, León C, McGrath JA, Vicente MÁ, Del Río M, de Lucas R, Sánchez-Ramón S, Escámez MJ.
Br J Dermatol. 2023 Nov 16;189(6):774-776. doi: 10.1093/bjd/ljad313.
Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
Vanden Oever M, Twaroski K, Osborn MJ, Wagner JE, Tolar J.
Pediatr Res. 2018 Jan;83(1-2):318-324. doi: 10.1038/pr.2017.244. Epub 2017 Nov 1.
Beyond the Surface: A Narrative Review Examining the Systemic Impacts of Recessive Dystrophic Epidermolysis Bullosa.
Popp C, Miller W, Eide C, Tolar J, McGrath JA, Ebens CL.
J Invest Dermatol. 2024 Sep;144(9):1943-1953. doi: 10.1016/j.jid.2024.03.008. Epub 2024 Apr 12.
